ICD-10 Code Finder
Use this interactive tool to easily locate the appropriate codes for your patients
Use the interactive code finder to quickly find the current ICD-10 codes for the anti-VEGF agent EYLEA. To begin, simply answer the following short questions.
The coding information discussed here is provided for informational purposes only, is subject to change, and should not be construed as legal or medical advice. The codes listed here may not apply to all patients or to all health plans; providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect the services and products furnished to a specific patient.
*International Classification of Diseases, 10th Revision, Clinical Modification.
†CPT codes, descriptions, and material are © 2011 American Medical Association. All rights reserved.
‡Healthcare Common Procedure Coding System (HCPCS).
§National Drug Code.
Specialty Pharmacy Providers
As an option, or if instructed by the patient’s payer, EYLEA may be obtained through our broad network of specialty pharmacy providers.
Regeneron does not recommend the use of any particular listed specialty pharmacy.
EYLEA Product Return Procedure
If EYLEA is rendered unusable after purchase, it may be returned to Regeneron and replaced, under certain circumstances. Returns are subject to adherence to Regeneron policies and procedures regarding the return of product and Regeneron’s right, at its sole discretion, to deny replacement when misuse is suspected.
Information About Returning EYLEA
As a condition of replacement, product should be returned, when possible
Note the condition of the vial:
- If vial is intact: Return to the address provided when you contact the patient support program
- If the vial is broken*: Submit pictures documenting the damage
Contact your distributor or specialty pharmacy if you believe EYLEA expired or was damaged in shipment
For product complaints and/or product returns, or to obtain appropriate forms and a list of required documents, call EYLEA4U® at 1-855-EYLEA4U (1-855-395-3248), Option 3.
*Broken vials do not have to be returned, but pictures documenting the damage should be submitted.
Regeneron Temporarily Extends EYLEA® (aflibercept) Injection Payment Terms
In response to the COVID-19 pandemic, Regeneron temporarily extends EYLEA® (aflibercept) Injection physician payment terms to 150 days, subject to distributor qualification.
COVID-19 is having a significant impact on the healthcare community and in some instances, it is limiting patient access to essential care. In response to the unprecedented situation facing physicians and their patients during this pandemic, Regeneron has temporarily extended payment terms for EYLEA purchases to authorized distributors. This has no impact on our current EYLEA return policies.
Physicians may now temporarily be eligible for payment terms of up to 150 days (previously 100 days), subject to distributor qualification. Please verify the timing and specific dating terms that apply to your office with your authorized distributors of record.
Regeneron is working with its authorized distributors of record to apply these new temporary terms for EYLEA (vial or pre-filled syringe) purchased on or after March 1, 2020. We aim to implement these new terms by April 1, 2020 though these temporary payment terms will be retroactively implemented, as noted above. These temporary payment terms are subject to change and will continue to be evaluated as the COVID-19 situation evolves.
Please contact your specialty distributor with questions or to apply these new terms.
For more on Regeneron’s scientific efforts to help address COVID-19, please visit our website: www.regeneron.com/covid19.